The CDC is offering a grant to enhance state population-based surveillance of major birth defects and use the collected data for public health action. The grant aims to improve surveillance methodologies, data quality, and timeliness by expanding data sources and utilizing electronic health records. Applicants are encouraged to follow national guidelines for conducting birth defects surveillance and demonstrate data utilization through publications, prevention strategies, referral to services, and evaluation of newborn screening outcomes. The grant seeks to identify associations between modifiable risk factors and variations in birth defect prevalence, ultimately informing policy decisions for improved healthcare services and utilization. Deadline for application submission is October 26, 2015.
Opportunity ID: 278643
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD16-1601 |
| Funding Opportunity Title: | Population-Based Surveillance of Birth Defects and Data Utilization for Public Health Action |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 14 |
| Assistance Listings: | 93.073 — Birth Defects and Developmental Disabilities – Prevention and Surveillance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 24, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 26, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Oct 26, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Nov 25, 2015 |
| Estimated Total Program Funding: | $9,800,000 |
| Award Ceiling: | $250,000 |
| Award Floor: | $150,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) State governments |
| Additional Information on Eligibility: | Eligible applicants that can apply for this funding opportunity are listed below: • Federally recognized or state-recognized American Indian/Alaska Native tribal governments • American Indian/Alaska native tribally designated organizations • Alaska Native health corporations • Urban Indian health organizations • Tribal epidemiology centers • State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) |
Additional Information
| Agency Name: | Centers for Disease Control – NCBDDD |
| Description: | Birth defects are a leading cause of infant mortality in the United States and contribute substantially to health care costs and life-long disabilities. They affect one in every 33 babies in the United States, account for more than 20% of all infant deaths, and contribute to $2.6 billion annually in hospital costs alone. The Birth Defects Prevention Act of 1998 directed CDC to carry out programs to collect data on birth defects and provide information to the public about the prevention of birth defects. Accurately tracking birth defects and analyzing the collected data is the first step in preventing birth defects. This FOA provides funding to improve population-based birth defects surveillance and translate the data collected for public health action to better understand the impact of birth defects on communities, drive population-based prevention strategies, improve referral to services for affected individuals and families, and link and evaluate health outcomes of children identified through newborn screening for critical congenital heart defects and other disorders. The purpose of this FOA is to enhance state population-based surveillance of major birth defects and to use the data for public health action. Surveillance activities should focus on improvements in surveillance methodologies such as expanding data sources, increasing remote access to electronic medical records, piloting innovative approaches to electronic health data, and other methods to improve data quality and timeliness. Applicants are strongly encouraged to follow the National Birth Defects Prevention Network’s Guidelines for Conducting Birth Defects Surveillance and National Standards for Data Quality. In addition to enhanced surveillance methodologies, applicants need to demonstrate data utilization through at least three of the following: 1) publications of epidemiologic studies for enhanced surveillance methodologies, impact and trends on communities, health service utilization, etc.; 2) data driven prevention strategies for populations at risk; 3) referral to services for affected individuals and families, including evaluation of the effectiveness of the referral activities; and 4) enhance surveillance of newborn screening for critical congenital heart defects and other disorders, and evaluate health outcomes of affected children. Identification and engagement with appropriate partners are key to successfully implement the surveillance and data utilization activities. While the overall prevalence of birth defects has remained stable over time, there is variation in the prevalence of specific birth defects. Timely, complete, and accurate surveillance data are needed to explore potential associations between modifiable risk factors and these observed variations. Additionally, because infants born with birth defects are living longer, expanded surveillance activities are needed to quantify the public health impact of birth defects and to inform policy decisions that can drive improved health care services and utilization. Increasing the number of birth defects surveillance systems that provide quality data will support efforts to explore epidemiologic studies of birth defects and guide the development and evaluation of primary and secondary prevention efforts. Furthermore, these activities directly address NCBDDD’s mission and strategic priorities as well as a number of other high impact public health programs, including the CDC Health Protection Goals, Healthy People 2020 objectives, and CDC’s Strategic Public Health Priorities. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Bill Paradies
wep2@cdc.gov Email:wep2@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 278643 Full Announcement-1 -> cdc-rfa-dd16-1601 final 09 17 15.pdf
Packages
| Agency Contact Information: | Bill Paradies wep2@cdc.gov Email: wep2@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.073 | CDC-RFA-DD16-1601 | Population-Based Surveillance of Birth Defects and Data Utilization for Public Health Action | PKG00218322 | Aug 24, 2015 | Oct 26, 2015 | View |
Package 1
Mandatory forms
278643 SF424_2_1-2.1.pdf
278643 SF424A-1.0.pdf
278643 HHS_CheckList_2_1-2.1.pdf
278643 Project-1.1.pdf
278643 Budget-1.1.pdf
Optional forms
278643 Other-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
